UBS ETF In order to proceed, you must confirm that you are a qualified or institutional investor based in Norway.

The following information does not constitute distribution.

Please note that this webpage gives qualified investors access to the entire UBS ETF product offering. Therefore, some products on this webpage may NOT be authorized, recognised or registered for distribution neither in Finland, nor in your country or as the case may be nor in any other country. No distribution must be carried out for it. No marketing material must be handed out to clients on any occasion. The presentation of marketing material in client halls is strictly forbidden. Reference to these funds in client mailings must not be made. In case that you don't want or are not allowed to see the full ETF range, please do not proceed.

For marketing and information purposes by UBS.

For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

UBS funds under Luxembourg and Irish law

Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management

This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

© UBS 2020. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Back

UBS ETF (LU) Bloomberg Barclays US Liquid Corporates 1-5 UCITS ETF (hedged to CHF) A-acc

Net asset value 13.9344 CHF

Last update

24.01.2020

ISIN: LU1048315755

Asset Class:  Fixed Income

Download all data as XLS File

10 largest constituents

#

Securities

Coupon

Maturity

ISIN

Currency

Price

Weight %

1

CVS HEALTH CORP 3.70000% 18-09.03.23

3.70

09.03.2023

US126650CV07

USD

104.28

2.98

2

ABBVIE INC-144A 2.60000% 19-21.11.24

2.60

21.11.2024

US00287YBQ17

USD

101.28

1.81

3

BROADCOM CORP/CAYMAN FIN LTD 3.00000% 18-15.01.22

3.00

15.01.2022

US11134LAD10

USD

101.29

1.69

4

BRISTOL-MYERS SQUIBB CO-144A 2.90000% 19-26.07.24

2.90

26.07.2024

US110122BZ08

USD

103.42

1.60

5

CIGNA CORP 3.75000% 19-15.07.23

3.75

15.07.2023

US125523AF71

USD

105.06

1.55

6

WELLS FARGO & CO 3.75000% 19-24.01.24

3.75

24.01.2024

US95000U2C66

USD

105.82

1.50

7

BANK OF AMERICA CORP 3.550%/3M LIBOR+78BP 18-05.03.24

3.55

05.03.2024

US06051GHF90

USD

103.98

1.48

8

OCCIDENTAL PETROLEUM CORP 2.90000% 19-15.08.24

2.90

15.08.2024

US674599CW33

USD

101.51

1.44

9

ABBVIE INC-144A 2.30000% 19-21.11.22

2.30

21.11.2022

US00287YBL20

USD

100.51

1.43

10

WELLS FARGO & CO 2.406%/VAR 19-30.10.25

2.41

30.10.2025

US95000U2H53

USD

100.50

1.43

This overview shows the portfolio positions. The actual positions of the ETF may deviate from this. Source: State Street, 23.01.2020

Composition data

Ticker

CBUS5S SW

Total net assets

142,853,462.06

Total outstanding ETF Shares

10,251,896.00

Base currency

CHF

Source: State Street, 27.01.2020

Disclaimer

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm. Barclays US Liquid Corporates UCITS, Barclays Euro Area Liquid Corporate 1-5 Year Index, Barclays US Liquid Corporate 1-5 Year Index and Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index (the “Barclays Indices”) are trademarks of Barclays Capital or its affiliates and have been licensed for use in connection with UBS Exchange Traded Funds. UBS Exchange Traded Funds based on Barclays Indices are not sponsored or endorsed by Barclays Capital or its affiliates. Neither Barclays Capital nor its affiliates make any representation regarding the advisability of investing in UBS Exchange Traded Funds. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary. © UBS 2020. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.